more energy on semaglutide a GLP-1 and wondering why your drink is destroying you? 🤢 It's not in your head. Ozempic, tirzepatide and along with other GLPs slow your gut motility so all Your weight loss journey starts

In the landmark STEP 1 trial, published in the New England Journal of Medicine in 2021, patients taking semaglutide 2.4 mg (Wegovy) lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group

Retrieved 21 November 2008

Krger-Genge A, Blocki A, Franke RP, Jung F

167,168 In hepatocytes, elevated lipid load and insulin resistance increase mitochondrial -oxidation activity, accompanied by electron leakage and respiratory chain disruption, resulting in substantial ROS production, which exacerbates lipid peroxidation, autophagic dysfunction, and pyroptosis

Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease